Get the Stockscreener App
2.02
0.50%
0.01
After Hours:
2.02
Cerus Corp stock is traded at $2.02, with a volume of 922.78K.
It is up +0.50% in the last 24 hours and up +19.53% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$2.01
Open:
$2.02
24h Volume:
922.78K
Relative Volume:
0.56
Market Cap:
$388.19M
Revenue:
$206.13M
Net Income/Loss:
$-15.64M
P/E Ratio:
-24.48
EPS:
-0.0825
Net Cash Flow:
$1.11M
1W Performance:
+5.21%
1M Performance:
+19.53%
6M Performance:
+27.04%
1Y Performance:
+51.88%
1-Day Range:
$2.00
$2.04
1-Week Range:
$1.84
$2.05
52-Week Range:
$1.15
$2.955
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.02 | 386.27M | 206.13M | -15.64M | 1.11M | -0.0825 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Q3 2025 Cerus Corp Earnings Call Transcript - GuruFocus
Cerus (CERS) CFO receives 200,000-share RSU grant, lifts holdings to 1.24M - Stock Titan
Cerus (CERS) Chief Legal Officer receives 200,000-share RSU stock grant - Stock Titan
Cerus Corp (CU2.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
CERS SEC FilingsCerus 10-K, 10-Q, 8-K Forms - Stock Titan
CERS Technical Analysis & Stock Price Forecast - Intellectia AI
Cerus Corp (CERS) Stock Price Quote Today & Current Price Chart - Capital.com
Vanguard disaggregates holdings after realignment; Cerus Corp (NASDAQ: CERS) - Stock Titan
Soleus Capital (NASDAQ: CERS) discloses 5.1% position in Cerus - Stock Titan
Aug Shorts: Is Cerus Corporation in accumulation or distribution phase2026 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Wall Street Recap: What is the PEG ratio of Cerus Corporation2026 Technical Patterns & Detailed Earnings Play Strategies - baoquankhu1.vn
Vivek Jayaraman Sells 165,200 Shares of Cerus (NASDAQ:CERS) Stock - Defense World
Cerus Appoints Vivek Jayaraman As Chief Executive Officer - citybiz
Cerus Corp: chief medical officer Benjamin sells $168k in shares - Investing.com Nigeria
Cerus Corp COO Jayaraman sells $273k in shares By Investing.com - Investing.com Australia
Cerus names COO Vivek Jayaraman as next CEO effective July 1 By Investing.com - Investing.com South Africa
Cerus Corp: chief medical officer Benjamin sells $168k in shares By Investing.com - Investing.com South Africa
Cerus CFO Kevin Green sells $169k in shares - Investing.com Nigeria
Cerus Corp CFO green sells $211k in shares - Investing.com
Cerus Corp CEO Greenman sells $742k in shares By Investing.com - Investing.com Canada
Cerus Corp CEO Greenman sells $742k in shares - Investing.com Nigeria
Insider Selling: Cerus (NASDAQ:CERS) CEO Sells 447,757 Shares of Stock - MarketBeat
Insider Selling: Cerus (NASDAQ:CERS) Insider Sells 113,008 Shares of Stock - MarketBeat
Cerus Corp CFO green sells $211k in shares By Investing.com - Investing.com Australia
Cerus Corp (CERS) CMO sells 101,740 shares for RSU tax withholding - Stock Titan
Jensen, Cerus Corp chief legal officer, sells $187k in stock - Investing.com
Cerus Corp COO Jayaraman sells $273k in shares - Investing.com
Cerus (CERS) CLO sells shares under 10b5-1 to cover taxes - Stock Titan
Cerus (CERS) COO share sale covers taxes on RSU vesting - Stock Titan
Cerus (CERS) CEO sells 447,757 shares under 10b5-1 tax plan - Stock Titan
Cerus (CERS) CFO share sale covers taxes on RSU vesting - Stock Titan
Cerus (CERS) promotes COO Vivek Jayaraman to CEO with $3M equity awards - Stock Titan
Cerus (CERS) Announces Leadership Transition with New CEO Appoin - GuruFocus
Cerus names COO Vivek Jayaraman as next CEO effective July 1 - Investing.com
COO who drove Cerus revenue past $200M will now run the company - Stock Titan
Greenman, Cerus Corp president, sells $156k in CERS stock - Investing.com Nigeria
Baker BROS. Advisors LP Sells 2,875,499 Shares of Cerus Corporation $CERS - MarketBeat
Cerus (NASDAQ:CERS) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
CERS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cerus Corp COO Jayaraman sells $68k in shares By Investing.com - Investing.com Nigeria
Cerus CFO Kevin Green sells $169k in shares By Investing.com - Investing.com Australia
Cerus (NASDAQ:CERS) CFO Kevin Dennis Green Sells 55,225 Shares - MarketBeat
Cerus corp chief medical officer sells shares worth $250k By Investing.com - Investing.com Australia
Cerus corp chief medical officer sells shares worth $250k - Investing.com
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Greenman William Mariner | President and CEO |
Mar 12 '26 |
Sale |
1.66 |
447,757 |
742,023 |
4,998,493 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 12 '26 |
Sale |
1.66 |
127,544 |
211,366 |
1,040,551 |
| Benjamin Richard J | Chief Medical Officer |
Mar 12 '26 |
Sale |
1.66 |
101,740 |
168,604 |
777,361 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 05 '26 |
Sale |
2.06 |
55,225 |
113,902 |
1,195,891 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 06 '26 |
Sale |
2.01 |
27,796 |
55,745 |
1,168,095 |
| Benjamin Richard J | Chief Medical Officer |
Mar 05 '26 |
Sale |
2.06 |
61,233 |
126,305 |
943,762 |
| Benjamin Richard J | Chief Medical Officer |
Mar 09 '26 |
Sale |
1.88 |
40,426 |
76,029 |
879,101 |
| Benjamin Richard J | Chief Medical Officer |
Mar 06 '26 |
Sale |
2.01 |
24,235 |
48,603 |
919,527 |
| Jensen Chrystal | Chief Legal Officer |
Mar 06 '26 |
Sale |
2.01 |
30,845 |
61,860 |
1,059,139 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 06 '26 |
Sale |
2.01 |
34,094 |
68,376 |
1,912,874 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):